Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
How does choice of enzyme replacement therapy and monitoring parameters for late-onset Pompe disease differ from infantile onset disease?
Related Questions
When would you use memantine for autism spectrum disorder?
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
When, if ever, do you use therapeutic hypothermia (targeted temperature management) in a non-neotal pediatric cardiac arrest patient?
How do you counsel on the risks of developing anti-drug antibodies when using intrathecal enzyme replacement therapy for lysosomal storage disorders?
How do you discontinue ketogenic diets previously used as a treatment for epilepsy?
When and how do you perform genetic testing for congenital myasthenia gravis in seronegative cases?
What factors do you consider when determining eligibility for hematopoietic stem cell therapies for metachromatic leukodystrophy?
How would you approach a toddler with alternating head tilt episodes lasting for weeks?
When do you consider cannabidiol for treatment of epilepsy?
How do pediatric functional neurologic disorders differ from adult disorders in their presentation and diagnosis?
